tiprankstipranks
Alnylam reports KARDIA-2  zilebesiran study met primary endpoint of lower SBP
PremiumThe FlyAlnylam reports KARDIA-2 zilebesiran study met primary endpoint of lower SBP
2M ago
Alnylam Pharmaceuticals Finalizes Exit Deal with EVP Franchini
PremiumCompany Announcements
Alnylam Pharmaceuticals Finalizes Exit Deal with EVP Franchini
2M ago
Alnylam Pharmaceuticals’ New Regulation Risk – A Cause for Worry?
PremiumMarket News
Alnylam Pharmaceuticals’ New Regulation Risk – A Cause for Worry?
2M ago
Intellia Therapeutics price target lowered to $24 from $38 at Baird
PremiumThe FlyIntellia Therapeutics price target lowered to $24 from $38 at Baird
2M ago
Alnylam post-earnings selloff overdone, says Citi
PremiumThe Fly
Alnylam post-earnings selloff overdone, says Citi
2M ago
Alnylam downgraded to Neutral from Buy at Goldman Sachs
PremiumThe Fly
Alnylam downgraded to Neutral from Buy at Goldman Sachs
2M ago
Is ALNY a Buy, Before Earnings?
PremiumPre-EarningsIs ALNY a Buy, Before Earnings?
2M ago
Chardan lays out top 4 biotech picks for 2024
PremiumThe Fly
Chardan lays out top 4 biotech picks for 2024
3M ago
Ionis Pharmaceuticals price target raised to $70 from $65 at RBC Capital
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $70 from $65 at RBC Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100